These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1233209)

  • 1. Persistent parotid pain due to guanacline.
    Parker M
    Eur J Clin Pharmacol; 1975 Feb; 8(2):131-4. PubMed ID: 1233209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proceedings: Ultrastructure of damaged nerves in the parotid gland of patients with hypertension treated by guanacline: morphological substrates of parotid pain].
    Pirsig W; Proescher HJ; Donath K
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1973 Dec; 205(2):103-9. PubMed ID: 4785473
    [No Abstract]   [Full Text] [Related]  

  • 3. [Persisting parotis pain following guanacline therapy].
    Huep WW; Bock KD
    Med Klin; 1972 Aug; 67(32):1048-52. PubMed ID: 5070915
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sialadenosis of the parotid gland after long-term treatment with antihypertensive agents (Guanacline). Ultrastructural alterations].
    Donath K; Seifert G; Pirsig W
    Virchows Arch A Pathol Pathol Anat; 1973; 360(1):33-44. PubMed ID: 4199230
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alterations of the autonomic nervous system of parotid gland after administration of antihypertensiva (guanacline). Ultrastructural and fluorescence cytochemical findings on the parotid gland of the rat (author's transl)].
    Donath K; Seifert G
    Virchows Arch A Pathol Pathol Anat; 1973 Nov; 361(2):109-20. PubMed ID: 4203383
    [No Abstract]   [Full Text] [Related]  

  • 6. [Renin-angiotensin system in persisting orthostatic hypotension following guanacline].
    Wende W; Ochs HG
    Verh Dtsch Ges Inn Med; 1973; 79():752-4. PubMed ID: 4364050
    [No Abstract]   [Full Text] [Related]  

  • 7. Guanacline, a new hypotensive drug.
    Le Moine Parker M; Bullen M
    Med J Aust; 1969 Jan; 1(4):159-62. PubMed ID: 5779041
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proceedings: Experimental parotid changes following chemically induced sympaticus degeneration].
    Donath K; Burkhardt A
    Verh Dtsch Ges Pathol; 1973; 57():449. PubMed ID: 4142289
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the sympathetic nerves in the parotid gland following guanacline medication. Ultrastructural observations (author's transl)].
    Donath K; Seifert G; Pirsig W
    Virchows Arch A Pathol Pathol Anat; 1973 Sep; 360(3):195-207. PubMed ID: 4201286
    [No Abstract]   [Full Text] [Related]  

  • 10. Species and structural specificity of the lipopigment accumulation and neuronal destruction induced by N-(2-guanidinoethyl)-4-methyl-1,2,5,6-tetrahydropyridine (guanacline).
    Johnson EM; Palmatier MA; Rydel RE; Manning PT
    Brain Res; 1986 Sep; 383(1-2):100-9. PubMed ID: 3768685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with guanacline, a new antihypertensive agent.
    Hall GV; Michell G
    Med J Aust; 1968 Jun; 1(24):1047-8. PubMed ID: 4874340
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experiences with Leron (guanacline) in the treatment of hypertension.
    Seedat YK
    S Afr Med J; 1970 May; 44(19):562-3. PubMed ID: 5420832
    [No Abstract]   [Full Text] [Related]  

  • 13. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
    Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic neuronal destruction in macaque monkeys by guanethidine and guanacline.
    Palmatier MA; Schmidt RE; Plurad SB; Johnson EM
    Ann Neurol; 1987 Jan; 21(1):46-52. PubMed ID: 3827214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Persistent orthostatic hypotonia following guanacline therapy].
    Bock KD; Heimsoth V
    Dtsch Med Wochenschr; 1969 Feb; 94(6):256-6 passim. PubMed ID: 5762679
    [No Abstract]   [Full Text] [Related]  

  • 16. [Irreversible parotid gland pain following administration of guanaclin].
    Bock KD; Huep WW
    Dtsch Med Wochenschr; 1971 Oct; 96(42):1649-50. PubMed ID: 5142764
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacotherapy of hypertension and its significance for the function of the salivary glands (author's transl)].
    Chilla R; Arglebe C
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1425-8. PubMed ID: 126377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
    Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer.
    Bussels B; Maes A; Flamen P; Lambin P; Erven K; Hermans R; Nuyts S; Weltens C; Cecere S; Lesaffre E; Van den Bogaert W
    Radiother Oncol; 2004 Dec; 73(3):297-306. PubMed ID: 15588874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
    Mayer O; Polívková H
    Cor Vasa; 1987; 29(4 Suppl 1):37-41. PubMed ID: 3315449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.